Expertise & Collaboration
Our diverse, disciplined team works together to build and maintain concentrated portfolios of what we believe are the highest-quality companies worldwide.
- Location: Boca Raton, FL
- Head of Team: Damon Ficklin, Portfolio Manager & Analyst
- Average Team Member Experience: 15 years (as of 09-30-2024)
Our Investment Philosophy
Concentrated Portfolio: High Active Share
Risk Management: “Don’t Lose” Mentality
Long Holding/Compounding Period: Time Arbitrage
Outcome Orientation: “Weighing Machine vs. Voting Machine”
Meet the Team
APPROACH
Our Strategic Approach
Large Company Growth Stock Selection Process
We select stocks through our time-tested process, fine-tuned over three decades. Our in-depth research
and stringent guardrails support objective screening and monitoring. We identify and invest in only our best ideas—companies we believe demonstrate competitive advantages and sustainable growth potential across long time horizons.
The Polen Large Company Growth strategies typically hold 20 to 35 companies that the portfolio management team feels are the highest-quality growth names. Examples as of 09/30/2024 include:
Adobe is the market leader in digital and creative software solutions. With low leverage, high profitability, high recurring revenues, and a capital-light business model, Adobe continues to strengthen its value proposition as a mission-critical partner to governments and enterprises. The need for a digital-first customer experience is accelerating, in our view, and we expect the demand for Adobe’s services to increase.
LVMH is a collection of some of the world’s largest luxury brands, including Louis Vuitton, and other global megabrands like Celine, Christian Dior, Dom Perignon, Bulgari, Sephora, and Tiffany. Our research indicates the company enjoys multiple competitive advantages that reinforce each other, including significant scale, a well-honed playbook for nurturing and growing brands, and irreplicable brand heritage. We believe demand will remain resilient and that continued growth in omnichannel luxury shopping will support market share gains.
ICON is an Ireland-based leading contract research organization. It provides outsourced services for the planning, enrollment, and execution of clinical trials for the biomedical industry. Over time, we believe ICON will benefit from its scale, network, and expertise as the trend toward outsourcing increases and R&D spending grows over time.